Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physostigmine induced reduction of analgesic treatment (PIRAT) in abdominal hysterectomy
2006-006839-51Phase 2Terminated
- Sponsor
- Franz Köhler Chemie
- Start
- May 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing Physostigmine with Placebo (2 arms). Primary endpoint: Postoperative morphine consumption via PCA over 24 hours. Started May 2007; status: terminated.
02
Drugs
physostigmine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2006-006839-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006839-51.